Ravasio R, Antonuzzo L, Danova M, Pronzato P. A Budget impact analysis of pegfilgrastim biosimilar in the treatment of febrile neutropenia in Italy: Analisi di budget impact del biosimilare di pegfilgrastim nel trattamento della neutropenia febbrile in Italia. AboutOpen [Internet]. 2020 Mar. 2 [cited 2024 Nov. 21];7(1):4-8. Available from: https://journals.aboutscience.eu/index.php/aboutopen/article/view/2030